COVID-19 Ag & Flu A/B Combo Self Test

Product catalog summary

Overview: The COVID-19 Ag & Flu A/B Combo Self Test is designed for the simultaneous qualitative detection of Influenza type A (including H1N1, H3N2, and H5N1), Influenza type B, and SARS-CoV-2 antigens in respiratory specimens. This test is particularly useful for patients suspected of having multiple viral infections, which is a common trend among COVID-19 patients.

Key Features:

Differentiation: The test can differentiate between SARS-CoV-2 and Influenza viruses, addressing the challenge of similar symptoms caused by these infections.
Efficiency: It rapidly differentiates three infections in one test, providing results in 20 minutes.
Convenience: The test is easy to operate, requires no extra equipment, and uses a non-invasive nasal swab sample.
Robustness: The all-in-one package is suitable for point-of-care testing and does not require refrigerated transportation, allowing storage at room temperature.

Test Procedures:

Check the test kit contents.
Open the package and take out the swab.
Insert the swab tip 2.5 cm (1 inch) into the nasal cavity and rotate it five times.
Place the extraction tube in the holder and install the nozzle cap.
Add two drops of the sample to the test device and wait for 15-30 minutes for results.

Manufacturer Information: The test is produced by Xiamen Biotime Biotechnology Co., Ltd., located in Xiamen, Fujian, China. Contact details include phone, fax, email, and website information.

Catalog excerpts

COVID-19 Ag & Flu A/B Combo Self Test Diﬀerentiation of SARS-CoV-2 and Inﬂuenza Viruses COVID-19 Ag & Flu A/B Combo Self Test utilizes colloidal gold immunochromatography allowing the simultaneous qualitative detection of Inﬂuenza type A(including H1N1, H3N2 and H5N1), Inﬂuenza type B and SARS-CoV-2 antigens in respiratory specimens from patients suspected of infec

Open the catalog to page 1

Why choose Combo test？ Multiple viral infections is a trend, and many COVID-19 patients have multiple viral infections. Coinfection in COVID-19 patients may worsen disease outcomes. We found that a higher proportion of patients with COVID-19 were coinfected with one or more additional pathogens. [ From JCLA Journal of Clinical Laboratory Analysis ] Symptoms caused by the infection of SARS-CoV-2 and Inﬂuenza viruses are very similar, which brings a huge challenge in diagnosis and timely medical treatment. Biotime COVID-19 Ag & Flu A/B Combo Test with diﬀerentiated detection of the multiple pathogens...

Open the catalog to page 2